Changzhou Qianhong Bio-Pharma Co.,Ltd.’s Net Profit Rose 39.8% in First Three Quarters of 2022

Changzhou Qianhong Bio-Pharma Co.,Ltd. (常州千红生化制药股份有限公司) (002550.SZ) reported a net profit of 257.2 million yuan in the first three quarters of 2022, up 39.8% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 20.5% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 404 million yuan in total liabilities, with a liability-to-asset ratio of 14.6%.